{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:42:48Z","timestamp":1793407368262,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An increasing body of evidence implicates the resident gut microbiota as playing a critical role in type 2 diabetes (T2D) pathogenesis. We previously reported significant improvement in postprandial glucose control in human participants with T2D following 12-week administration of a 5-strain novel probiotic formulation (\u2018WBF-011\u2019) in a double-blind, randomized, placebo controlled setting (NCT03893422). While the clinical endpoints were encouraging, additional exploratory measurements were needed in order to link the motivating mechanistic hypothesis - increased short-chain fatty acids - with markers of disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we report targeted and untargeted metabolomic measurements on fasting plasma (<jats:italic>n<\/jats:italic>\u2009=\u2009104) collected at baseline and end of intervention. Butyrate and ursodeoxycholate increased among participants randomized to WBF-011, along with compelling trends between butyrate and glycated haemoglobin (HbA1c). In vitro monoculture experiments demonstrated that the formulation\u2019s <jats:italic>C. butyricum<\/jats:italic> strain efficiently synthesizes ursodeoxycholate from the primary bile acid chenodeoxycholate during butyrogenic growth. Untargeted metabolomics also revealed coordinated decreases in intermediates of fatty acid oxidation and bilirubin, potential secondary signatures for metabolic improvement. Finally, improvement in HbA1c was limited almost entirely to participants not using sulfonylurea drugs. We show that these drugs can inhibit growth of formulation strains in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>To our knowledge, this is the first description of an increase in circulating butyrate or ursodeoxycholate following a probiotic intervention in humans with T2D, adding support for the possibility of a targeted microbiome-based approach to assist in the management of T2D. The efficient synthesis of UDCA by <jats:italic>C. butyricum<\/jats:italic> is also likely of interest to investigators of its use as a probiotic in other disease settings. The potential for inhibitory interaction between sulfonylurea drugs and gut microbiota should be considered carefully in the design of future studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-021-02415-8","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T03:02:47Z","timestamp":1641610967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8879-3954","authenticated-orcid":false,"given":"Paul J.","family":"McMurdie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6974-6009","authenticated-orcid":false,"given":"Magdalena K.","family":"Stoeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-2119","authenticated-orcid":false,"given":"Nicholas","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8279-4021","authenticated-orcid":false,"given":"Madeleine","family":"Nemchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-0281","authenticated-orcid":false,"given":"Christian M. K.","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1578-6777","authenticated-orcid":false,"given":"Surabhi","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-4873","authenticated-orcid":false,"given":"Connor T.","family":"Skennerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-8189","authenticated-orcid":false,"given":"Michael","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-1288","authenticated-orcid":false,"given":"Orville","family":"Kolterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-8344","authenticated-orcid":false,"given":"John","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"2415_CR1","unstructured":"CDC. National Diabetes Statistics Report, 2020: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC); 2020:2\u201313. https:\/\/www.cdc.gov\/diabetes\/library\/features\/diabetes-stat-report.html. Accessed 26 Apr 2021"},{"key":"2415_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","volume":"1","author":"PD Cani","year":"2019","unstructured":"Cani PD, Van Hul M, Lefort C, Depommier C, Rastelli M, Everard A. Microbial regulation of organismal energy homeostasis. Nat Metab. 2019;1:34\u201346.","journal-title":"Nat Metab"},{"key":"2415_CR3","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1172\/JCI129194","volume":"129","author":"K Dabke","year":"2019","unstructured":"Dabke K, Hendrick G, Devkota S. The gut microbiome and metabolic syndrome. J Clin Invest. 2019;129:4050\u20137.","journal-title":"J Clin Invest"},{"key":"2415_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4239\/wjd.v10.i3.154","volume":"10","author":"Y Kyriachenko","year":"2019","unstructured":"Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes. 2019;10:154\u201368.","journal-title":"World J Diabetes"},{"key":"2415_CR5","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11:5015.","journal-title":"Nat Commun"},{"key":"2415_CR6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","volume":"8","author":"Y Gu","year":"2017","unstructured":"Gu Y, Wang X, Li J, Zhang Y, Zhong H, Liu R, et al. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun. 2017;8:1785.","journal-title":"Nat Commun"},{"key":"2415_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-0488","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care. 2016;39:198\u2013205.","journal-title":"Diabetes Care"},{"key":"2415_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Vel\u00e1squez-Mej\u00eda EP, Carmona JA, Abad JM, et al. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care. 2017;40:54\u201362.","journal-title":"Diabetes Care"},{"key":"2415_CR9","doi-asserted-by":"publisher","first-page":"573891","DOI":"10.3389\/fendo.2020.573891","volume":"11","author":"TTB Cao","year":"2020","unstructured":"Cao TTB, Wu K-C, Hsu J-L, Chang C-S, Chou C, Lin C-Y, et al. Effects of non-insulin anti-hyperglycemic agents on gut microbiota: a systematic review on human and animal studies. Front Endocrinol (Lausanne). 2020;11:573891.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2415_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","volume":"163","author":"D Zeevi","year":"2015","unstructured":"Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163:1079\u201394.","journal-title":"Cell"},{"key":"2415_CR11","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590.","journal-title":"EBioMedicine"},{"key":"2415_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","volume":"65","author":"MC Dao","year":"2016","unstructured":"Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426\u201336.","journal-title":"Gut"},{"key":"2415_CR13","doi-asserted-by":"crossref","unstructured":"Vital M, Karch A, Pieper DH. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems. 2017;2.","DOI":"10.1128\/mSystems.00130-17"},{"key":"2415_CR14","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary Fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332\u201345.","journal-title":"Cell"},{"key":"2415_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11:577\u201391.","journal-title":"Nat Rev Endocrinol"},{"key":"2415_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52:1\u20138.","journal-title":"J Gastroenterol"},{"key":"2415_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00004836-200603000-00015","volume":"40","author":"JMW Wong","year":"2006","unstructured":"Wong JMW, de Souza R, Kendall CWC, Emam A, Jenkins DJA. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235\u201343.","journal-title":"J Clin Gastroenterol"},{"key":"2415_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrgastro.2012.156","volume":"9","author":"HJ Flint","year":"2012","unstructured":"Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9:577\u201389.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1 Pt 2","key":"2415_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1746.2006.04213.x","volume":"21","author":"S Sengupta","year":"2006","unstructured":"Sengupta S, Muir JG, Gibson PR. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol. 2006;21(1 Pt 2):209\u201318.","journal-title":"J Gastroenterol Hepatol"},{"key":"2415_CR20","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.7150\/jca.25324","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Wu Y, He L, Wu L, Wang X, Liu Z. Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J Cancer. 2018;9:2510\u20137.","journal-title":"J Cancer"},{"key":"2415_CR21","doi-asserted-by":"crossref","unstructured":"Perraudeau F, McMurdie P, Bullard J, Cheng A, Cutcliffe C, Deo A, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020;8.","DOI":"10.1136\/bmjdrc-2020-001319"},{"key":"2415_CR22","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1099\/ijsem.0.003041","volume":"68","author":"SA Shetty","year":"2018","unstructured":"Shetty SA, Zuffa S, Bui TPN, Aalvink S, Smidt H, De Vos WM. Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. Nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces. Int J Syst Evol Microbiol. 2018;68:3741\u20136.","journal-title":"Int J Syst Evol Microbiol"},{"key":"2415_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","volume":"13","author":"MK Stoeva","year":"2021","unstructured":"Stoeva MK, Garcia-So J, Justice N, Myers J, Tyagi S, Nemchek M, et al. Butyrate-producing human gut symbiont, clostridium butyricum, and its role in health and disease. Gut Microbes. 2021;13:1\u201328.","journal-title":"Gut Microbes"},{"key":"2415_CR24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41598-018-37679-0","volume":"9","author":"P Patakova","year":"2019","unstructured":"Patakova P, Branska B, Sedlar K, Vasylkivska M, Jureckova K, Kolek J, et al. Acidogenesis, solventogenesis, metabolic stress response and life cycle changes in Clostridium beijerinckii NRRL B-598 at the transcriptomic level. Sci Rep. 2019;9:1371.","journal-title":"Sci Rep"},{"key":"2415_CR25","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3390\/nu11081943","volume":"11","author":"MAG Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez MAG, Canfora EE, Jocken JWE, Blaak EE. The short-chain fatty acid acetate in body weight control and insulin sensitivity. Nutrients. 2019;11:1943.","journal-title":"Nutrients."},{"key":"2415_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/gut.19.9.819","volume":"19","author":"NI McNeil","year":"1978","unstructured":"McNeil NI, Cummings JH, James WP. Short chain fatty acid absorption by the human large intestine. Gut. 1978;19:819\u201322.","journal-title":"Gut"},{"key":"2415_CR27","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1038\/s41598-019-48775-0","volume":"9","author":"M M\u00fcller","year":"2019","unstructured":"M\u00fcller M, Hern\u00e1ndez MAG, Goossens GH, Reijnders D, Holst JJ, Jocken JWE, et al. Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans. Sci Rep. 2019;9:12515.","journal-title":"Sci Rep"},{"key":"2415_CR28","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1210\/jc.2012-4109","volume":"98","author":"AC Meyer-Gerspach","year":"2013","unstructured":"Meyer-Gerspach AC, Steinert RE, Keller S, Malarski A, Schulte FH, Beglinger C. Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans. J Clin Endocrinol Metab. 2013;98:3351\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2415_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/dom.12648","volume":"18","author":"M Hansen","year":"2016","unstructured":"Hansen M, Scheltema MJ, Sonne DP, Hansen JS, Sperling M, Rehfeld JF, et al. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion. Diabetes Obes Metab. 2016;18:571\u201380.","journal-title":"Diabetes Obes Metab"},{"key":"2415_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"2415_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m A, Sayin SI, Marschall H-U, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41\u201350.","journal-title":"Cell Metab"},{"key":"2415_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657\u201369.","journal-title":"Cell Metab"},{"key":"2415_CR33","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science. 1999;284:1362\u20135.","journal-title":"Science"},{"key":"2415_CR34","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278:9435\u201340.","journal-title":"J Biol Chem"},{"key":"2415_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7:678\u201393.","journal-title":"Nat Rev Drug Discov"},{"key":"2415_CR36","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.csda.2011.02.014","volume":"55","author":"M Koller","year":"2011","unstructured":"Koller M, Stahel WA. Sharpening Wald-type inference in robust regression for small samples. Comput Stat Data Anal. 2011;55:2504\u201315.","journal-title":"Comput Stat Data Anal"},{"key":"2415_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/01621459.1972.10481279","volume":"67","author":"DF Bauer","year":"1972","unstructured":"Bauer DF. Constructing confidence sets using rank statistics. J Am Stat Assoc. 1972;67:687\u201390.","journal-title":"J Am Stat Assoc"},{"key":"2415_CR38","doi-asserted-by":"publisher","first-page":"e0179200","DOI":"10.1371\/journal.pone.0179200","volume":"12","author":"E Danese","year":"2017","unstructured":"Danese E, Salvagno GL, Negrini D, Brocco G, Montagnana M, Lippi G. Analytical evaluation of three enzymatic assays for measuring total bile acids in plasma using a fully-automated clinical chemistry platform. Plos One. 2017;12:e0179200.","journal-title":"Plos One"},{"key":"2415_CR39","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3762\/bjoc.14.33","volume":"14","author":"F Tonin","year":"2018","unstructured":"Tonin F, Arends IWCE. Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. Beilstein J Org Chem. 2018;14:470\u201383.","journal-title":"Beilstein J Org Chem"},{"key":"2415_CR40","first-page":"1","volume":"55","author":"MB Wilk","year":"1968","unstructured":"Wilk MB, Gnanadesikan R. Probability plotting methods for the analysis for the analysis of data. Biometrika. 1968;55:1\u201317.","journal-title":"Biometrika"},{"key":"2415_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/wics.101","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi H, Williams LJ. Principal component analysis. WIREs Comp Stat. 2010;2:433\u201359.","journal-title":"WIREs Comp Stat"},{"key":"2415_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/gb-2003-4-4-210","volume":"4","author":"X Cui","year":"2003","unstructured":"Cui X, Churchill GA. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol. 2003;4:210.","journal-title":"Genome Biol"},{"key":"2415_CR43","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.1073\/pnas.0914005107","volume":"107","author":"R Bourgon","year":"2010","unstructured":"Bourgon R, Gentleman R, Huber W. Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A. 2010;107:9546\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2415_CR44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s42255-020-0188-7","volume":"2","author":"J Frampton","year":"2020","unstructured":"Frampton J, Murphy KG, Frost G, Chambers ES. Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat Metab. 2020;2:840\u20138.","journal-title":"Nat Metab"},{"key":"2415_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1042\/bst0280182","volume":"28","author":"RR Ramsay","year":"2000","unstructured":"Ramsay RR. The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions. Biochem Soc Trans. 2000;28:182\u20136.","journal-title":"Biochem Soc Trans"},{"key":"2415_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","volume":"7","author":"TR Koves","year":"2008","unstructured":"Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 2008;7:45\u201356.","journal-title":"Cell Metab"},{"key":"2415_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman MG, Vaz FM, Houten SM, Soeters MR. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes. 2013;62:1\u20138.","journal-title":"Diabetes"},{"key":"2415_CR48","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/oby.2009.510","volume":"18","author":"SJ Mihalik","year":"2010","unstructured":"Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FGS, et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010;18:1695\u2013700.","journal-title":"Obesity (Silver Spring)"},{"key":"2415_CR49","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3390\/nu11092022","volume":"11","author":"AIS Sobczak","year":"2019","unstructured":"Sobczak AIS, Blindauer CA, Stewart AJ. Changes in plasma free fatty acids associated with Type-2 diabetes. Nutrients. 2019;11:2022.","journal-title":"Nutrients."},{"key":"2415_CR50","doi-asserted-by":"publisher","first-page":"e5410","DOI":"10.7717\/peerj.5410","volume":"6","author":"DM Libert","year":"2018","unstructured":"Libert DM, Nowacki AS, Natowicz MR. Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: amino acid and acylcarnitine levels change along a spectrum of metabolic wellness. PeerJ. 2018;6:e5410.","journal-title":"PeerJ"},{"key":"2415_CR51","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2147\/DMSO.S294894","volume":"14","author":"D Cheng","year":"2021","unstructured":"Cheng D, Zhao X, Yang S, Cui H, Wang G. Metabolomic signature between metabolically healthy overweight\/obese and metabolically unhealthy overweight\/obese: a systematic review. Diabetes Metab Syndr Obes. 2021;14:991\u20131010.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2415_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.5114\/aoms.2015.53304","volume":"11","author":"D Sola","year":"2015","unstructured":"Sola D, Rossi L, Schianca GPC, Maffioli P, Bigliocca M, Mella R, et al. Sulfonylureas and their use in clinical practice. Arch Med Sci. 2015;11:840\u20138.","journal-title":"Arch Med Sci"},{"key":"2415_CR53","unstructured":"Medscape from WebMD. Glimepiride, glyburide, and glipizide: dosing, indications, interactions, adverse effects, and more. https:\/\/reference.medscape.com\/drug\/. Accessed 12 Apr 2021."},{"key":"2415_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fendo.2019.00029","volume":"10","author":"C G\u00e9rard","year":"2019","unstructured":"G\u00e9rard C, Vidal H. Impact of gut microbiota on host glycemic control. Front Endocrinol (Lausanne). 2019;10:29.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2415_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","volume":"42","author":"BA McLean","year":"2021","unstructured":"McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ. Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation. Endocr Rev. 2021;42:101\u201332.","journal-title":"Endocr Rev"},{"key":"2415_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/genes8100250","volume":"8","author":"SA Montandon","year":"2017","unstructured":"Montandon SA, Jornayvaz FR. Effects of antidiabetic drugs on gut microbiota composition. Genes (Basel). 2017;8:250.","journal-title":"Genes (Basel)."},{"key":"2415_CR57","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/BF00401417","volume":"35","author":"JC Henquin","year":"1992","unstructured":"Henquin JC. The fiftieth anniversary of hypoglycaemic sulphonamides. How did the mother compound work? Diabetologia. 1992;35:907\u201312.","journal-title":"Diabetologia"},{"key":"2415_CR58","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1128\/AAC.02327-12","volume":"57","author":"JF Kreisberg","year":"2013","unstructured":"Kreisberg JF, Ong NT, Krishna A, Joseph TL, Wang J, Ong C, et al. Growth inhibition of pathogenic bacteria by sulfonylurea herbicides. Antimicrob Agents Chemother. 2013;57:1513\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2415_CR59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.plaphy.2007.12.004","volume":"46","author":"RG Duggleby","year":"2008","unstructured":"Duggleby RG, McCourt JA, Guddat LW. Structure and mechanism of inhibition of plant acetohydroxyacid synthase. Plant Physiol Biochem. 2008;46:309\u201324.","journal-title":"Plant Physiol Biochem"},{"key":"2415_CR60","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/advances\/nmaa133","volume":"12","author":"T Rittiphairoj","year":"2021","unstructured":"Rittiphairoj T, Pongpirul K, Janchot K, Mueller NT, Li T. Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and Meta-analysis. Adv Nutr. 2021;12:722\u201334.","journal-title":"Adv Nutr"},{"key":"2415_CR61","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s00125-018-4632-0","volume":"61","author":"D Houghton","year":"2018","unstructured":"Houghton D, Hardy T, Stewart C, Errington L, Day CP, Trenell MI, et al. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes. Diabetologia. 2018;61:1700\u201311.","journal-title":"Diabetologia"},{"key":"2415_CR62","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.3390\/nu12113239","volume":"12","author":"O Ojo","year":"2020","unstructured":"Ojo O, Feng Q-Q, Ojo OO, Wang X-H. The role of dietary fibre in modulating gut microbiota Dysbiosis in patients with type 2 diabetes: a systematic review and Meta-analysis of randomised controlled trials. Nutrients. 2020;12:3239.","journal-title":"Nutrients."},{"key":"2415_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/ajcn\/nqz322","volume":"111","author":"NT Mueller","year":"2020","unstructured":"Mueller NT, Zhang M, Juraschek SP, Miller ER, Appel LJ. Effects of high-fiber diets enriched with carbohydrate, protein, or unsaturated fat on circulating short chain fatty acids: results from the OmniHeart randomized trial. Am J Clin Nutr. 2020;111:545\u201354.","journal-title":"Am J Clin Nutr"},{"key":"2415_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41522-020-0127-0","volume":"6","author":"PW Gilijamse","year":"2020","unstructured":"Gilijamse PW, Hartstra AV, Levin E, Wortelboer K, Serlie MJ, Ackermans MT, et al. Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome. NPJ Biofilms Microbiomes. 2020;6:16.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2415_CR65","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1113\/JP272613","volume":"595","author":"E Boets","year":"2017","unstructured":"Boets E, Gomand SV, Deroover L, Preston T, Vermeulen K, De Preter V, et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. J Physiol (Lond). 2017;595:541\u201355.","journal-title":"J Physiol (Lond)"},{"key":"2415_CR66","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00394-015-0985-z","volume":"55","author":"EVJ Boll","year":"2016","unstructured":"Boll EVJ, Ekstr\u00f6m LMNK, Courtin CM, Delcour JA, Nilsson AC, Bj\u00f6rck IME, et al. Effects of wheat bran extract rich in arabinoxylan oligosaccharides and resistant starch on overnight glucose tolerance and markers of gut fermentation in healthy young adults. Eur J Nutr. 2016;55:1661\u201370.","journal-title":"Eur J Nutr"},{"key":"2415_CR67","unstructured":"Identification of three clostridia strains capable of biotransforming chenodeoxycholic acid to ursodeoxycholic acid--\u300aJournal of Fudan University\u300b1990\u5e7402\u671f. https:\/\/en.cnki.com.cn\/Article_en\/CJFDTotal-FDXB199002008.htm. Accessed 11 Mar 2021."},{"key":"2415_CR68","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1007\/s10620-013-2879-3","volume":"58","author":"M Seo","year":"2013","unstructured":"Seo M, Inoue I, Tanaka M, Matsuda N, Nakano T, Awata T, et al. Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats. Dig Dis Sci. 2013;58:3534\u201344.","journal-title":"Dig Dis Sci"},{"key":"2415_CR69","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/BF02774577","volume":"17","author":"M Hosomi","year":"1982","unstructured":"Hosomi M, Tanida N, Shimoyama T. The role of intestinal bacteria in gallstone formation in animal model. A study on biliary lipid composition and bile acid profiles in bile, small intestinal contents and feces of clostridium butyricum Miyairi no. 588 monocontaminated mice. Gastroenterol Jpn. 1982;17:316\u201323.","journal-title":"Gastroenterol Jpn"},{"key":"2415_CR70","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fmicb.2020.00600","volume":"11","author":"W-W Wang","year":"2020","unstructured":"Wang W-W, Wang J, Zhang H-J, Wu S-G, Qi G-H. Supplemental clostridium butyricum modulates lipid metabolism through shaping gut microbiota and bile acid profile of aged laying hens. Front Microbiol. 2020;11:600.","journal-title":"Front Microbiol"},{"key":"2415_CR71","doi-asserted-by":"publisher","first-page":"10641","DOI":"10.1007\/s00253-020-10976-3","volume":"104","author":"T Hagi","year":"2020","unstructured":"Hagi T, Geerlings SY, Nijsse B, Belzer C. The effect of bile acids on the growth and global gene expression profiles in Akkermansia muciniphila. Appl Microbiol Biotechnol. 2020;104:10641\u201353.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2415_CR72","doi-asserted-by":"crossref","unstructured":"Van den Bossche L, Hindryckx P, Devisscher L, Devriese S, Van Welden S, Holvoet T, et al. Ursodeoxycholic acid and its taurine- or Glycine-conjugated species reduce Colitogenic Dysbiosis and equally suppress experimental colitis in mice. Appl Environ Microbiol. 2017;83(7):e02766\u201316.","DOI":"10.1128\/AEM.02766-16"},{"key":"2415_CR73","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","volume":"62","author":"M Mueller","year":"2015","unstructured":"Mueller M, Thorell A, Claudel T, Jha P, Koefeler H, Lackner C, et al. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J Hepatol. 2015;62:1398\u2013404.","journal-title":"J Hepatol"},{"key":"2415_CR74","doi-asserted-by":"publisher","first-page":"25088","DOI":"10.1074\/jbc.M113.452516","volume":"288","author":"H Yadav","year":"2013","unstructured":"Yadav H, Lee J-H, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem. 2013;288:25088\u201397.","journal-title":"J Biol Chem"},{"key":"2415_CR75","doi-asserted-by":"publisher","first-page":"G53","DOI":"10.1152\/ajpgi.00346.2017","volume":"315","author":"CB Christiansen","year":"2018","unstructured":"Christiansen CB, Gabe MBN, Svendsen B, Dragsted LO, Rosenkilde MM, Holst JJ. The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon. Am J Physiol Gastrointest Liver Physiol. 2018;315:G53\u201365.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2415_CR76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364\u201371.","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"2415_CR77","doi-asserted-by":"publisher","first-page":"S434","DOI":"10.2337\/diabetes.51.2007.S434","volume":"51","author":"PE MacDonald","year":"2002","unstructured":"MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AMF, Light PE, Wheeler MB. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes. 2002;51(Suppl 3):S434\u201342.","journal-title":"Diabetes"},{"key":"2415_CR78","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molmet.2016.05.012","volume":"5","author":"TU Greiner","year":"2016","unstructured":"Greiner TU, B\u00e4ckhed F. Microbial regulation of GLP-1 and L-cell biology. Mol Metab. 2016;5:753\u20138.","journal-title":"Mol Metab"},{"key":"2415_CR79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41598-019-56743-x","volume":"10","author":"S Ducastel","year":"2020","unstructured":"Ducastel S, Touche V, Trabelsi M-S, Boulinguiez A, Butruille L, Nawrot M, et al. The nuclear receptor FXR inhibits glucagon-like Peptide-1 secretion in response to microbiota-derived short-chain fatty acids. Sci Rep. 2020;10:174.","journal-title":"Sci Rep"},{"key":"2415_CR80","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","volume":"6","author":"HS Yoon","year":"2021","unstructured":"Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim J-H, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6:563\u201373.","journal-title":"Nat Microbiol"},{"key":"2415_CR81","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molcel.2020.03.005","volume":"78","author":"A Koh","year":"2020","unstructured":"Koh A, B\u00e4ckhed F. From association to causality: the role of the gut microbiota and its functional products on host metabolism. Mol Cell. 2020;78:584\u201396.","journal-title":"Mol Cell"},{"key":"2415_CR82","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41467-020-20313-x","volume":"12","author":"RR Rodrigues","year":"2021","unstructured":"Rodrigues RR, Gurung M, Li Z, Garc\u00eda-Jaramillo M, Greer R, Gaulke C, et al. Transkingdom interactions between lactobacilli and hepatic mitochondria attenuate western diet-induced diabetes. Nat Commun. 2021;12:101.","journal-title":"Nat Commun"},{"key":"2415_CR83","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature16504","volume":"529","author":"ED Sonnenburg","year":"2016","unstructured":"Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016;529:212\u20135.","journal-title":"Nature"},{"key":"2415_CR84","doi-asserted-by":"publisher","first-page":"9457","DOI":"10.1021\/acs.analchem.8b02100","volume":"90","author":"JJ Hsiao","year":"2018","unstructured":"Hsiao JJ, Potter OG, Chu T-W, Yin H. Improved LC\/MS methods for the analysis of metal-sensitive Analytes using Medronic acid as a Mobile phase additive. Anal Chem. 2018;90:9457\u201364.","journal-title":"Anal Chem"},{"key":"2415_CR85","volume-title":"R: a Language and Environment for Statistical Computing","author":"R Core Team","year":"2020","unstructured":"R Core Team. R: a Language and Environment for Statistical Computing. 2020."},{"key":"2415_CR86","first-page":"520","volume-title":"R for Data Science: Import, Tidy, Transform, Visualize, and Model Data","author":"H Wickham","year":"2017","unstructured":"Wickham H, Grolemund G. 12 Tidy data. In:  R for Data Science: Import, Tidy, Transform, Visualize, and Model Data. 1st ed. Sebastopol: O\u2019Reilly Media; 2017. p. 520.","edition":"1"},{"key":"2415_CR87","doi-asserted-by":"crossref","unstructured":"Xie Y, Allaire JJ, Grolemund G. R markdown: the definitive guide.\u00a0Boca Raton: Chapman and Hall\/CRC; 2018.","DOI":"10.1201\/9781138359444"},{"issue":"1","key":"2415_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25(1):1\u201318.","journal-title":"J Stat Softw."},{"key":"2415_CR89","unstructured":"Maechler M, Rousseeuw P, Croux C, Todorov V, Ruckstuhl A, Salibian-Barrera M, Verbeke T, Koller M, Conceicao EL, Anna di Palma M. robustbase: Basic Robust Statistics. R package version 0.93-9. 2021. http:\/\/robustbase.r-forge.r-project.org\/."},{"key":"2415_CR90","volume-title":"ggplot2 - elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2 - elegant graphics for data analysis. 2nd ed. Cham: Springer International Publishing; 2016.","edition":"2"},{"key":"2415_CR91","volume-title":"patchwork: the composer of plots","author":"TL Pedersen","year":"2020","unstructured":"Pedersen TL. patchwork: the composer of plots; 2020."},{"key":"2415_CR92","volume-title":"ggbeeswarm: categorical scatter (violin point) plots","author":"E Clarke","year":"2017","unstructured":"Clarke E, Sherrill-Mix S. ggbeeswarm: categorical scatter (violin point) plots; 2017."},{"key":"2415_CR93","volume-title":"ggridges: ridgeline plots in \u201cggplot2.\u201d","author":"CO Wilke","year":"2020","unstructured":"Wilke CO. ggridges: ridgeline plots in \u201cggplot2.\u201d; 2020."},{"key":"2415_CR94","volume-title":"ggrepel: Automatically position non-overlapping text labels with \u201cggplot2.\u201d","author":"K Slowikowski","year":"2020","unstructured":"Slowikowski K. ggrepel: Automatically position non-overlapping text labels with \u201cggplot2.\u201d; 2020."},{"key":"2415_CR95","volume-title":"magrittr: a forward-pipe operator for R","author":"SM Bache","year":"2014","unstructured":"Bache SM, Wickham H. magrittr: a forward-pipe operator for R; 2014."},{"key":"2415_CR96","volume-title":"data.table: extension of \u2018data.frame\u2019","author":"M Dowle","year":"2020","unstructured":"Dowle M, Srinivasan A. data.table: extension of \u2018data.frame\u2019; 2020."},{"key":"2415_CR97","volume-title":"pspline: penalized smoothing splines","author":"J Ramsey","year":"2017","unstructured":"Ramsey J, Ripley B. pspline: penalized smoothing splines; 2017."},{"key":"2415_CR98","volume-title":"rmdformats: HTML output formats and templates for \u201crmarkdown\u201d documents","author":"J Barnier","year":"2021","unstructured":"Barnier J. rmdformats: HTML output formats and templates for \u201crmarkdown\u201d documents; 2021."},{"key":"2415_CR99","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1101\/gr.263566.120","volume":"30","author":"S Nurk","year":"2020","unstructured":"Nurk S, Walenz BP, Rhie A, Vollger MR, Logsdon GA, Grothe R, et al. HiCanu: accurate assembly of segmental duplications, satellites, and allelic variants from high-fidelity long reads. Genome Res. 2020;30:1291\u2013305.","journal-title":"Genome Res"},{"key":"2415_CR100","doi-asserted-by":"publisher","first-page":"e112963","DOI":"10.1371\/journal.pone.0112963","volume":"9","author":"BJ Walker","year":"2014","unstructured":"Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. Plos One. 2014;9:e112963.","journal-title":"Plos One"},{"key":"2415_CR101","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13059-015-0849-0","volume":"16","author":"M Hunt","year":"2015","unstructured":"Hunt M, Silva ND, Otto TD, Parkhill J, Keane JA, Harris SR. Circlator: automated circularization of genome assemblies using long sequencing reads. Genome Biol. 2015;16:294.","journal-title":"Genome Biol"},{"key":"2415_CR102","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"UniProt Consortium","year":"2021","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480\u20139.","journal-title":"Nucleic Acids Res"},{"key":"2415_CR103","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015;12:59\u201360.","journal-title":"Nat Methods"},{"key":"2415_CR104","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094\u2013100.","journal-title":"Bioinformatics"},{"key":"2415_CR105","first-page":"D440","volume":"48","author":"K Haug","year":"2020","unstructured":"Haug K, Cochrane K, Nainala VC, Williams M, Chang J, Jayaseelan KV, et al. MetaboLights: a resource evolving in response to the needs of its scientific community. Nucleic Acids Res. 2020;48:D440\u20134.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-021-02415-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-021-02415-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-021-02415-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T11:06:19Z","timestamp":1666523179000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-021-02415-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2415"],"URL":"https:\/\/doi.org\/10.1186\/s12866-021-02415-8","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original trial protocol was approved by a central institutional review board (Allendale, Old Lyme, Connecticut, USA), and was conducted in accordance with the Declaration of Helsinki as amended in 2013 and Good Clinical Practice guidelines. Written informed consent was obtained from each subject prior to participation in any trial activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees and stock\/stock option shareholders of Pendulum Therapeutics, Inc. (formerly known as \u2018Whole Biome Inc.\u2019). O.K. also owns stock in GlySens, Inc., has stock options in ViaCyte, Inc. and NanoPrecision Medical.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}